论文信息 - Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial - 字舞流文

Venetoclax, Lenalidomide and Rituximab for Patients with Relapsed or Refractory Mantle Cell Lymphoma - the Nordic Lymphoma Group NLG-MCL7 (VALERIA) Phase Ib-II Trial

M. Jerkeman | T. El‐Galaly | L. Meriranta | S. Leppä | M. Hutchings | I. Glimelius | C. Niemann | A. Kolstad | A. Pasanen | K. Wader | J. H. Christensen | J. Riise | R. Rask Kragh Jørgensen